EP1051141A4 - Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline - Google Patents

Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline

Info

Publication number: EP1051141A4
Authority: EP; European Patent Office
Prior art keywords: amylinagonist; pharmaceutical compositions; insulin; compositions containing; containing pharmaceutical
Prior art date: 1998-01-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98902526A

Other languages

German (de)

English (en)

Other versions

EP1051141A1 (fr

Inventor

Italian James L

Shankar Musunuri

Cale Ruby

Orville Kolterman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amylin Pharmaceuticals LLC

Original Assignee

Amylin Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-09

Filing date

1998-01-09

Publication date

2001-05-23

1998-01-09 Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC

1998-01-09 Priority claimed from PCT/US1998/000662 external-priority patent/WO1999034764A2/fr

2000-11-15 Publication of EP1051141A1 publication Critical patent/EP1051141A1/fr

2001-05-23 Publication of EP1051141A4 publication Critical patent/EP1051141A4/fr

Status Withdrawn legal-status Critical Current

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

EP98902526A 1998-01-09 1998-01-09 Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline Withdrawn EP1051141A4 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1998/000662 WO1999034764A2 (fr)	1998-01-09	1998-01-09	Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline

Publications (2)

Publication Number	Publication Date
EP1051141A1 EP1051141A1 (fr)	2000-11-15
EP1051141A4 true EP1051141A4 (fr)	2001-05-23

Family

ID=22266197

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98902526A Withdrawn EP1051141A4 (fr)	1998-01-09	1998-01-09	Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline

Country Status (2)

Country	Link
EP (1)	EP1051141A4 (fr)
AU (1)	AU5916298A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9171343B1 (en)	2012-09-11	2015-10-27	Aseko, Inc.	Means and method for improved glycemic control for diabetic patients
US9897565B1 (en)	2012-09-11	2018-02-20	Aseko, Inc.	System and method for optimizing insulin dosages for diabetic subjects
US9898585B2 (en)	2014-01-31	2018-02-20	Aseko, Inc.	Method and system for insulin management
US9486580B2 (en)	2014-01-31	2016-11-08	Aseko, Inc.	Insulin management
EP3050023B1 (fr)	2014-10-27	2021-08-25	Aseko, Inc.	Gestion sous-cutanée de patient externe
US11081226B2 (en)	2014-10-27	2021-08-03	Aseko, Inc.	Method and controller for administering recommended insulin dosages to a patient
AU2016308953B2 (en)	2015-08-20	2020-09-10	Glytec, Llc	Diabetes management therapy advisor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124314A (en) *	1987-08-26	1992-06-23	Amylin Pharmaceuticals, Inc.	Pharmaceutical compositions containing amylin

1998
- 1998-01-09 EP EP98902526A patent/EP1051141A4/fr not_active Withdrawn
- 1998-01-09 AU AU59162/98A patent/AU5916298A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124314A (en) *	1987-08-26	1992-06-23	Amylin Pharmaceuticals, Inc.	Pharmaceutical compositions containing amylin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REDALIEU E ET AL: "Pharmacokinetic effects of syringe mixing pramlintide, isophane insulin, and soluble insulin.", DIABETOLOGIA, vol. 40, no. Suppl. 1, 1997, 16th International Diabetes Federation Congress; Helsinki; 20-25 July 1997, pages A356, XP000990750 *

Also Published As

Publication number	Publication date
EP1051141A1 (fr)	2000-11-15
AU5916298A (en)	1999-07-26

Similar Documents

Publication	Publication Date	Title
DE69924999D1 (de)	2005-06-02	Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ATE331529T1 (de)	2006-07-15	Antigen enthaltende pharmazeutische zusammensetzung
DE69940904D1 (de)	2009-07-02	Pharmazeutische zusammensetzung enthaltend epothilone
ATE320244T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE69726015D1 (de)	2003-12-11	Pharmazeutische zusammensetzung enthaltend koenzym q-10
DK1001813T3 (da)	2003-07-28	Farmaceutiske formuleringer indeholdende voriconazol
DE60127002D1 (de)	2007-04-12	Pharmazeutische zusammensetzung
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
NO992339L (no)	1999-11-16	Farmasöytiske formuleringer
DE69923076D1 (de)	2005-02-10	Transthorakale arzneimittelabgabevorrichtung
ID27415A (id)	2001-04-05	Komposisi farmaseutik
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
ATE432707T1 (de)	2009-06-15	Pharmazeutische zubereitung
DE69900561D1 (de)	2002-01-24	Pharmazeutische Zusammensetzungen enthaltend Mupirocin
ID27201A (id)	2001-03-08	Komposisi farmasi
DE60211183D1 (de)	2006-06-08	Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE59910298D1 (de)	2004-09-23	Pharmazeutische levothyroxinzubereitung
ATE366128T1 (de)	2007-07-15	Pharmazeutische zusammensetzung
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
DE59801987D1 (de)	2001-12-06	Pharmazeutische zusammensetzung enthaltend peptichemio
DE10084344T1 (de)	2002-07-11	Cyclosporin enthaltende pharmazeutische Zusammensetzung
DE69830154D1 (de)	2005-06-16	Pharmazeutische zusammensetzungen
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
ID30032A (id)	2001-11-01	Formulasi farmasi
EP1051141A4 (fr)	2001-05-23	Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline

Legal Events

Date	Code	Title	Description
2000-09-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-11-15	17P	Request for examination filed	Effective date: 19990806
2000-11-15	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-04-11	RIN1	Information on inventor provided before grant (corrected)	Inventor name: KOLTERMAN, ORVILLE Inventor name: RUBY, CALE Inventor name: MUSUNURI, SHANKAR Inventor name: L'ITALIAN, JAMES
2001-05-16	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 7/00 A, 7A 61K 38/28 B, 7A 61K 38/28 J, 7A 61K 38:22 J
2001-05-23	A4	Supplementary search report drawn up and despatched	Effective date: 20010406
2001-05-23	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2003-12-17	17Q	First examination report despatched	Effective date: 20031029
2004-07-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-09-15	18D	Application deemed to be withdrawn	Effective date: 20040309
2007-08-17	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1030360 Country of ref document: HK